FrancophonIA/ELRC3.0 huggingface dataset:
English: • treatment of moderate to severe manic episodes in bipolar disorder and major depressive episodes in bipolar disorder;
Maltese: • kura ta' episodji manijaċi moderati sa severi f'disturb bipolari u episodji dipressivi maġġuri f'disturb bipolari;
English: What are Seroquel and Seroquel XR?
Maltese: X'inhuma Seroquel u Seroquel XR?
English: Seroquel and Seroquel XR are antipsychotic medicines that contain the active substance quetiapine.
Maltese: Seroquel u Seroquel XR huma mediċini antipsikotiċi li fihom is-sustanza attiva quetiapine.
English: Seroquel and Seroquel XR were identified by the Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) as needing harmonisation.
Maltese: Seroquel u Seroquel XR ġew identifikati mill-Grupp ta' Koordinazzjoni għal Għarfien Reċiproku u Proċeduri Deċentralizzati - Uman (CMDh) bħala fil-bżonn ta' armonizzazzjoni.
English: The CHMP also harmonised other sections of the SmPC including sections 4.4 (special warnings and precautions for use) and 4.8 (undesirable effects).
Maltese: Is-CHMP armonizza wkoll sezzjonijiet oħra tas-SmPC inklużi is-sezzjonijiet 4,4 (twissijiet speċjali u prekawzjonijiet għall-użu) u 4.8 (effetti mhux mixtieqa).
English: • prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment.
Maltese: • prevenzjoni ta' rikorrenza ta' episodji manijaċi jew dipressivi f'pazjenti b'disturb bipolari li rrispondew qabel għal kura b'quetiapine.
English: Additionally, the data available show that newborns who were exposed to antipsychotics (including quetiapine) during late pregnancy (third trimester) are at risk of side effects including agitation, somnolence, breathing and feeding problems.
Maltese: Barra minn hekk, id-dejta disponibbli turi li trabi tat-twelid li ġew esposti għal antipsikotiċi (inkluż quetiapine) tard waqt it-tqala (it-tielet trimestru) huma f'riskju ta' effetti sekondarji inklużi aġitazzjoni, ħedla, problemi ta' nifs u tmigħ.
English: The exact mechanism of action of quetiapine is unknown, but it attaches to several receptors on the surface of nerve cells in the brain, including the receptors for the neurotransmitters dopamine and serotonin.
Maltese: Il-mekkaniżmu ta' azzjoni eżatt ta' quetiapine mhuwiex magħruf, iżda huwa jeħel ma' diversi riċetturi fuq il-wiċċ taċ-ċelloli tan-nervituri fil-moħħ, inkluż ir-riċetturi għan-newrotrażmettituri dopamina u serotonina.
English: Having reviewed the data available on the use of quetiapine during pregnancy, the CHMP concluded that no definite conclusion can be drawn on the risk of malformations in the unborn child when the medicine is used during early pregnancy (first trimester).
Maltese: Wara li rreveda d-dejta disponibbli dwar l-użu ta' quetiapine waqt it-tqala, is-CHMP ikkonkluda li ebda konklużjoni definittiva ma tista' tinħareġ dwar ir-riskju ta' malformazzjonijiet fit-tarbija mhux imwielda meta l-mediċina tintuża kmieni waqt it-tqala (l-ewwel trimestru).
English: Seroquel XR can also continue to be used as add-on to ongoing treatment for major depressive episodes in patients with major depressive disorder who have had sub-optimal response to treatment with other antidepressants.
Maltese: Seroquel XR jista' wkoll jibqa' jintuża bħala żieda f'kura għaddejja għal episodji dipressivi maġġuri f'pazjenti b'disturb dipressiv maġġuri li kellhom rispons għall-kura mhux ideali b'antidepressanti oħrajn.
English: After reviewing the available data supporting the use of the medicines, the CHMP agreed that Seroquel and Seroquel XR can continue to be used for the treatment of schizophrenia and treatment and prevention of bipolar disorder, but recommended harmonised wordings for these indications as follows:
Maltese: Wara li rriveda dejta disponibbli li tappoġġa l-użu ta' dawn il-mediċini, is-CHMP qabel li Seroquel u Seroquel XR jistgħu jibqgħu jintużaw għall-kura ta' skiżofrenja u kura u prevenzjoni ta' disturb bipolari, iżda rrakkomanda formulazzjonijiet armonizzati għal dawn l-indikazzjonijiet kif ġej:
English: Seroquel and Seroquel XR are authorised in the EU via national procedures.
Maltese: Seroquel u Seroquel XR huma awtorizzati fl-UE permezz ta' proċeduri nazzjonali.
English: They are also used for the prevention and treatment of bipolar disorder, a mental illness in which patients have manic episodes (periods of abnormally high mood), alternating with periods of normal mood, as well as episodes of depression.
Maltese: Jintużaw ukoll għall-prevenzjoni u l-kura ta' disturb bipolari, marda mentali fejn ilpazjenti jkollhom episodji manijaċi (perjodi ta' burdati għoljin b'mod anormali), li jalternaw ma' perjodi ta' burdata normali, kif ukoll episodji ta' dipressjoni.
English: They are used in patients with schizophrenia, a mental illness with a number of symptoms, including disorganised thinking and speech, hallucinations (hearing or seeing things that are not there), suspiciousness and delusions (false beliefs).
Maltese: Jintużaw f'pazjenti bi skizofrenja, marda mentali b'numru ta' sintomi, li jinkludu ħsieb u diskors diżorganizzat, alluċinazzjonijiet (is-smigħ u d-dehra ta' oġġetti li ma jkunux hemm), suspetti u delużjonijiet (twemmin falz).
English: On 22 May 2014, the European Medicines Agency completed a review of Seroquel and Seroquel XR.
Maltese: Fit-22 ta' Mejju 2014, l-Aġenzija Ewropea tal-Mediċini temmet reviżjoni ta' Seroquel u Seroquel XR. IlKumitat tal-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) tal-Aġenzija kkonkluda li hemm bżonn li tiġi armonizzata l-informazzjoni ta' preskrizzjoni għal dawn il-mediċini fl-Unjoni Ewropea (UE).
English: On 12 June 2013, the European Commission referred the matter to the CHMP in order to harmonise the marketing authorisations for Seroquel and Seroquel XR in the EU.
Maltese: Fit-12 ta' Ġunju 2013, il-Kummissjoni Ewropea rreferiet il-kwistjoni lis-CHMP sabiex jarmonizza lawtorizzazzjonijiet għat-tqegħid fis-suq għal Seroquel u Seroquel XR fl-UE.
English: 4.2 Posology and method of administration
Maltese: .2 Pożoloġija u metodi ta' kif jingħata
English: Why were Seroquel and Seroquel XR reviewed?
Maltese: Għaliex Seroquel u Seroquel XR ġew riveduti?
English: Seroquel XR can also be used as add-on treatment in major depression.
Maltese: Seroquel XR jista' jintuża wkoll bħala kura ta' żieda (add-on) f'dipressjoni maġġuri.
English: EMA/206629/2016 EMEA/H/C/000609
Maltese: EU/1/05/314/001
English: Other information about Kepivance:
Maltese: Mhux magħruf:
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom
Maltese: Nelson Road Longmont, Colorado 80503 L-Istati Uniti
English: It contains the active substance
Maltese: MANIFATTURTAS-SUSTANZA BIJOLOĠIKA ATTIVA U
English: How does Kepivance work?
Maltese: Meta tinghata Kepivance
English: The most common side effects with Kepivance (seen in more than 1 patient in 10) are dysgeusia (taste disturbances), increased levels of lipase and amylase (enzymes used in digestion), hypertrophy (increase in the number or size of cells) or discoloration of the mouth and tongue, rash, pruritus (itching), erythema (redness), arthralgia (joint pain), oedema (swelling), pain and pyrexia (fever).
Maltese: L-effikaċja u s-sigurtà ta' palifermin kienu stabbiliti fi studju randomised, double-blind u kkontrollat bil-plaċebo fejn il-pazjenti rċivew terapija ċitotossika ta' doża għolja li kienet tikkonsisti f'irradjazzjoni frazzjonata tal-ġisem kollu (doża totali ta' 12 Gy; Jum -8 sa -5), doża għolja ta' etoposide (60 mg/kg; Jum -4), u doża għolja ta' cyclophosphamide (100 mg/kg; Jum -2) segwita minn appoġġ b'PBPC għall-kura ta' tumuri malinni ematoloġiċi (Limfoma Mhux ta' Hodgkin (NHL), marda ta' Hodgkin, Lewkimja Mijelojda Akuta (AML), Lewkimja Limfoċitika Akuta (ALL), Lewkimja Mijelojda Kronika (CML), Lewkimja Limfoċitika Kronika (CLL), jew mijeloma multipla).
English: This summary was last updated in 03-2016.
Maltese: Data tal-aħħar tiġdid: 23 ta' Settembru 2010
English: The medicine can only be obtained with a prescription.
Maltese: Mediċini oħra u Kepivance
English: The full EPAR for Kepivance can be found here.
Maltese: Kepivance huwa trab abjad disponibbli f'kunjetti.
English: Three doses are given on three consecutive days before myeloablative therapy, finishing 24 to 48 hours before the therapy.
Maltese: L-aħħar minn tliet dożi li jingħataw qabel il-kimoterapija u radjuterapija, trid tingħata mill inqas 24 sa 48 siegħa qabel tibda l-kimoterapija u radjuterapija.
English: Kepivance is used to decrease the frequency, duration and severity of oral mucositis (inflammation of the lining of the mouth, ranging from soreness and redness to severe ulceration).
Maltese: Kepivance jintuża biex inaqqas il-frekwenza, it-tul u-severità tas-sintomi ta' mukożite orali.
English: Kepivance is used in adults who are likely to develop severe mucositis because they have blood cancer, and are being treated with myeloablative chemotherapy (medicines to destroy the bone marrow) in combination with radiotherapy (treatment with radiation) and an autologous haematopoietic stem-cell transplant (a transplant of their own blood-producing cells).
Maltese: Ma hemmx esperjenza b'dożi ta' Kepivance ta' aktar minn 80 mikrogramma/kg/kuljum mogħti ġolvini f'pazjenti fuq perjodu ta' ġimagħtejn (3 dożi qabel u 3 dożi wara t-terapija mijeloablattiva).
English: The use of Kepivance should be supervised by a doctor who has experience in anticancer therapy.
Maltese: Reazzjonijiet avversi minn provi kliniċi u rappurtaġġ spontanju.
English: The active substance in Kepivance, palifermin, is a growth factor that stimulates the ‘epithelial' cells that line the mouth and gastrointestinal tract to grow and develop.
Maltese: Madankollu, l-amministrazzjoni ta' palifermin ma affettwatx l-effett antikoagulanti tal-eparina fil-kundizzjonijiet sperimentali (doża waħdanija, reġimen tad-doża subterapewtiku).
English: The European Commission granted a marketing authorisation valid throughout the European Union for Kepivance on 25 October 2005.
Maltese: Ġeneralment, id-dissoluzzjoni ta' Kepivance tieħu inqas minn 5 minuti.
English: This document is a summary of the European Public Assessment Report (EPAR) for Kepivance.
Maltese: DATA TA' REVIŻJONI TAT-TEST
English: Kepivance has been compared with placebo (a dummy treatment) in one main study in 212 adults receiving chemotherapy and radiotherapy for a blood cancer (mostly non-Hodgkin's lymphoma).
Maltese: F'dan l-istudju (n = 281), pazjenti li jbagħtu minn mijeloma multipla rċevew trattament bil-melfalan (200 mg/m2) qabel it-trapjant taċ-ċelluli staminali ematopojetiċi awtologi.
English: At the request of the CHMP, the company carried out a further study comparing two schedules of Kepivance with placebo.
Maltese: Kepivance hu prodott sterili iżda mhuwiex ippreservat u hu intenzjonat biex jintuża darba biss.
English: For the full list of all side effects reported with Kepivance, see the package leaflet.
Maltese: Id-data ta' meta tiskadi tirreferi għall-aħħar ġurnata ta' dak ix-xahar.
English: Kepivance stimulates the growth of the epithelial cells, helping to reduce the incidence, severity and duration of oral mucositis in cancer patients undergoing intensive therapy.
Maltese: Ma kienet osservata l-ebda differenza relatata mas-sess tal-persuna fil-farmakokinetika ta' palifermin.
English: The study involved 281 adults who were receiving chemotherapy to treat multiple myeloma (a type of blood cancer), but without any radiotherapy.
Maltese: Ir-reġimen ta' kundizzjonament kien jikkonsisti mill-irradjazzjoni tal-ġisem kollu (TBI - total body irradiation), etoposide u cyclophosphamide.
English: The full EPAR for Brineura can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Brineura contains the active substance cerliponase alfa.
Maltese: Brineura fih is-sustanza attiva cerliponase alfa.
English: The summary of the opinion of the Committee for Orphan Medicinal Products for Brineura can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
Maltese: Is-sommarju tal-opinjoni tal-Kumitat għall-Prodotti Mediċinali Orfni għal Brineura jinstab fis-sit elettroniku tal-Aġenzija: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
English: Because the number of patients with CLN2 is low, the disease is considered ‘rare', and Brineura was designated an ‘orphan medicine' (a medicine used in rare diseases) on 13 March 2013.
Maltese: -marda hija kkunsidrata ‘rari', u Brineura ġie kklassifikat bħala ‘mediċina orfni' (mediċina li tintuża f'mard rari) fit-13 ta' Marzu 2013.
English: Other information about Brineura
Maltese: Informazzjoni oħra dwar Brineura
English: Patients with CLN2 lack an enzyme required for normal brain development called tripeptidyl-peptidase1 (TPP1).
Maltese: -moħħ li tissejjaħ tripeptidyl-peptidase-1 (TPP1).
English: The most common side effects with Brineura (which may affect more than 1 in 5 people) are fever, low levels of protein in CSF (the fluid in the brain and spinal cord), abnormalities in ECG (a test of the heart's activity), vomiting, upper respiratory tract infections (nose and throat infections), and hypersensitivity (allergic) reactions.
Maltese: -fluwidu fil-moħħ u fis-sinsla tad-dahar), anormalitajiet fl-ECG (test tal-attività tal-qalb), remettar, infezzjonijiet fl-apparat respiratorju fin-naħa ta' fuq (infezzjonijiet talimnieħer u tal-griżmejn), u reazzjonijiet (aller ġi
English: This is a summary of the European public assessment report (EPAR) for Brineura.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta
English: In a study in which 23 children (average age of 4 years) were treated with Brineura for almost a year, 20 of them (87%) did not experience the 2-point decline in movement and language skills seen historically in patients not receiving treatment.
Maltese: Fi studju li fih 23 wild (età medja ta' 4 snin) ġew ikkurati bi Brineura għal kważi sena, 20 minnhom (87 %) ma esperjenzawx it-tnaqqis ta ' 2
English: Why is Brineura approved?
Maltese: Għaliex ġie approvat Brineura?
English: What are the risks associated with Brineura?
Maltese: -riskji asso ċjati ma' Brineura?
English: Brineura cerliponase alfa
Maltese: ' neurocal ceroid lipofuscinosis tat
English: What information is still awaited for Brineura?
Maltese: Liema informazzjoni għadha mistennija għal Brineura?
English: The rating was done by doctors who gave patients individual scores for movement and language skills (where 0 means most severe and 3 is normal).
Maltese: Il-klassifikazzjoni saret minn tobba li taw lill-pazjenti punteġġi individwali għall-ħiliet tal-moviment u fillingwi (fejn 0 ifisser l-aktar sever u 3 huwa normali).
English: The medicine is infused directly into the brain in order to bypass the blood-brain barrier, a protective barrier that separates the blood stream from the brain, and prevents substances such as medicines, from entering brain tissue.
Maltese: Il-mediċina tiġi infuża direttament ġol-moħħ sabiex tevita l-barriera ematoenċefalika, barriera protettiva li tissepara l-fluss tad-demm mill-moħħ, u tipprevjeni sustanzi bħal mediċini, milli jidħlu fit-tessuti talmoħħ.
English: The active substance in Brineura, cerliponase alfa, is a copy of TPP1 and is used as a replacement for the missing enzyme.
Maltese: ' TPP1 u tintuża bħala sostitut tal-enzima nieqsa.
English: EPAR summary for the public
Maltese: Sommarju tal-EPAR għall-pubbliku cerliponase alfa
English: For the full list of all side effects reported with Brineura, see the package leaflet.
Maltese: -lista sħiħa tal-effetti sekondarji kollha bi Brineura, ara l-fuljett ta
English: How does Brineura work?
Maltese: -istudji?
English: Available data show that Brineura helps slow the decline in movement and language skills in patients with CLN2, a condition for which there are no other treatments.
Maltese: Data disponibbli turi li Brineura jgħin biex idewwem it-tnaqqis fil-ħiliet tal-moviment u fil-lingwi
English: Brineura is a medicine for treating neuronal ceroid lipofuscinosis type 2 (CLN2 disease), an inherited condition in children that leads to progressive brain damage.
Maltese: -kavità tal-fluwidu fil moħħ fejn tasal il-mediċina.
English: Brineura can only be obtained with a prescription.
Maltese: ' Brineura, inkluż ir
English: How is Brineura used?
Maltese: Brineura jista
English: Brineura must not be given to patients who have experienced life-threatening hypersensitivity (allergic) reactions with Brineura and whose symptoms re-occurred when Brineura was given again.
Maltese: Brineura m i li esperjenzaw reazzjonijiet (allerġiċi) ta' sensittività eċċessiva ta
English: Brineura has been shown in early studies to reduce the rate at which the disease worsens as measured with standard rating scale.
Maltese: Brineura huma akbar mir-riskji tiegħu u rrakkomanda li jkun approvat għall-użu fl-UE.
English: The full EPAR for Panacur AquaSol can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: • Trichuris suis (adult stages).
Maltese: • Trichuris suis (stadji adulti).
English: The active substance in Panacur AquaSol, fenbendazole, is a well-known anthelmintic, a substance that is active against helminths (parasitic worms).
Maltese: Is-sustanza attiva f'Panacur AquaSol, il-fenbendazole, hija antelmintika magħrufa sew, sustanza li hija attiva kontra l-elminti (dud parassitiku).
English: • Ascaris suum (adult intestinal and migrating larval stages);
Maltese: • Ascaris suum (stadji adulti intestinali u migratorji tal-larva);
English: Treatment with Panacur Aquasol at 1 mg/kg for 5 days in chickens reduced intestinal worm counts by 91% for Ascaridia galli and 98% for Heterakis gallinarum.
Maltese: Il-kura b'Panacur Aquasol b'1 mg/kg għal 5 ijiem fit-tiġieġ naqqset l-għadd ta' dud intestinali b'91 % għal Ascaridia galli u b'98 % għal Heterakis gallinarum.
English: • Oesophagostomum worms (adult stages);
Maltese: • Dud Oesophagostomum (stadji adulti);
English: Other information about Panacur AquaSol
Maltese: Informazzjoni oħra dwar Panacur AquaSol
English: This summary was last updated in January 2018.
Maltese: Dan is-sommarju ġie aġġornat l-aħħar f'Jannar 2018.
English: The first study included 432 pigs infected with Ascaris suum and the second study included 102 pigs infected with Oesophagostomum species.
Maltese: L-ewwel studju kien jinkludi 432 ħanżir infettati b'Ascaris suum u t-tieni studju kien jinkludi 102 ħnieżer infettati bi speċi Oesophagostomum.
English: The European Commission granted a marketing authorisation valid throughout the EU, for Panacur AquaSol on 09/12/2011.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-UE kollha għal Panacur AquaSol fid-9 ta' Diċembru 2011.
English: This is a summary of the European public assessment report (EPAR) for Panacur AquaSol.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Panacur AquaSol.
English: Panacur AquaSol treatment at 2 mg/kg for 5 days reduced worm counts by 100%.
Maltese: Il-kura b'Panacur AquaSol b'2 mg/kg għal 5 ijiem naqqset l-għadd tad-dud b'100 %.
English: • Heterakis gallinarum (L5 larvae and adult stages);
Maltese: • Heterakis gallinarum (stadji tal-larva L5 u adulti);
English: • Ascaridia galli (L5 larvae and adult stages);
Maltese: • Ascaridia galli (stadji tal-larva L5 u adulti);
English: For chickens, Panacur AquaSol is added to their drinking water in a quantity that aims to supply each chicken 1 mg fenbendazole per kg bodyweight daily for treating Ascaridia galli and Heterakis gallinarum and 2 mg fenbendazole per kg bodyweight daily for Capillaria infections.
Maltese: Għat-tiġieġ, Panacur AquaSol jiżdied mal-ilma tax-xorb tagħhom fi kwantità li timmira li tforni kull tiġieġa 1 mg fenbendazole għal kull kilogramma tal-piż tal-ġisem kujum għall-kura ta' Ascaridia galli u Heterakis gallinarum u 2 mg fenbendazole għal kull kilogramma tal-piż tal-ġisem kuljum għal infezzjonijiet Capillaria.
English: Repeated use of Panacur AquaSol or a similar anthelmintic may result in resistance.
Maltese: L-użu ripetut ta' Panacur AquaSol jew ta' antelmentika simili jista' jirriżulta f'reżistenza.
English: What are the risks associated with Panacur AquaSol?
Maltese: X'inhuma r-riskji assoċjati ma' Panacur AquaSol?
English: Panacur AquaSol is available as an oral suspension (200 mg/ml) for use in drinking water and can only be obtained with a prescription.
Maltese: Panacur AquaSol jiġi bħala sospensjoni orali (200 mg/ml) għall-użu fl-ilma tax-xorb u jista' jinkiseb biss b'riċetta ta' tabib.
English: • Capillaria worms (L5 larvae and adult stages).
Maltese: • Dud Capillaria (stadji tal-larva L5 u adulti).
English: For pigs, Panacur AquaSol is added to their drinking water in a quantity that aims to supply each pig 2.5 mg fenbendazole per kg bodyweight daily; this is done for two consecutive days for treatment and control of Ascaris suum and Oesophagostomum infections, and for three consecutive days to treat and control Trichuris suis.
Maltese: Għall-ħnieżer, Panacur AquaSol jiżdied mal-ilma tax-xorb tagħhom fi kwantità li għandha l-għan li tforni kull ħanżir 2.5 mg fenbendazole għal kull kilogramma tal-piż tal-ġisem kujum; dan isir għal jumejn konsekuttivi għall-kura u l-kontroll ta' infezzjonijiet b'Ascaris suum u Oesophagostomum, u għal tlett ijiem konsekuttivi għall-kura u l-kontroll ta' Trichuris suis.
English: After treatment with Panacur AquaSol, the number of Trichuris suis eggs was reduced by 90%.
Maltese: Wara l-kura b'Panacur AquaSol, in-numru tal-bajd ta' Trichuris suis naqas b'90 %.
English: It works by interfering with the formation of tube-like structures called ‘microtubules' inside the cells of the worm that are needed to perform vital functions such as growth and cell division.
Maltese: Din taħdem billi tinterferixxi mal-formazzjoni ta' strutturi simili għal tubu msejħa "mikrotubuli" fiċ-ċelloli tad-dudu li huma meħtieġa biex isiru funzjonijiet vitali bħattkabbir u bħad-diviżjoni taċ-ċelloli.
English: The effectiveness of Panacur AquaSol was also investigated in a field study involving chickens bred for laying and chickens bred for meat, infected with Ascaridia galli or Heterakis gallinarum.
Maltese: L-effikaċja ta' Panacur AquaSol ġiet investigata wkoll fi studju fuq il-post li involva tiġieġ mnissla biex ibidu u tiġieġ mnissla għal-laħam, infettati b'Ascaridia galli jew Heterakis gallinarum.
English: Why is Panacur AquaSol approved?
Maltese: Għaliex ġie approvat Panacur AquaSol?
English: The withdrawal period for chicken meat and offal is six days for the 1 mg fenbendazole/kg dose and nine days for the 2 mg fenbendazole/kg dose.
Maltese: Ilperjodu ta' tiżmim għal-laħam u l-ġewwieni tat-tiġieġa huwa sitt ijiem għad-doża ta' 1 mg fenbendazole/kg u disat ijiem għad-doża ta' 2 mg fenbendazole/kg.
English: How is Panacur AquaSol used?
Maltese: Kif jaħdem Panacur AquaSol?
English: A further field study involved chickens bred for laying and broiler breeders (chickens producing parent stock for chickens bred for meat), infected with Capillaria worms.
Maltese: Studju ieħor fuq il-post involva tiġieġ mnissla biex ibidu u tiġieġ tas-simna (tiġieġ li jipproduċu stokk ġenitur għal tiġieġ mnissla għal-laħam), infettati b'dud Capillaria.
English: Panacur AquaSol may be toxic if ingested by humans.
Maltese: Panacur AquaSol jista' jkun tossiku jekk jinbela' mill-bnedmin.
English: Panacur AquaSol is used for the treatment and control of three types of roundworm infections in the gut of pigs:
Maltese: Panacur AquaSol jintuża għall-kura u l-kontroll ta' tliet tipi ta' infezzjonijiet mill-ħniex fl-imsaren talħnieżer:
English: Orion Corporation Orionintie 1
Maltese: Il-Ġermanja Orion Corporation Orionintie 1
English: A-1090 Wien
Maltese: A-1090
English: SANOCHEMIA Pharmazeutika AG Boltzmanngasse 9a-11
Maltese: Il-Ġermanja SANOCHEMIA Pharmazeutika AG Boltzmanngasse 9a-11
English: PP Nature Balance Lizenz GmbH Habichthorst 34-36
Maltese: Il-Ġermanja PP Nature Balance Lizenz GmbH Habichthorst 34-36